6-Amino-4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-7-ethoxyquinoline-3-carbonitrile, 98%, 1g

(S)-4-Benzyl-3-pentanoyloxazolidin-2-one, 98+%, 100mg

4-Bromo-1-naphthalenol, 95.0%, 25g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-nitrophenyl)propanoic acid, 98%, 1g

VIPADENANT, 95%, 25mg

Methyl 2-amino-6-methylbenzoate, 95.0%, 1g

trans-4-N-Boc-Aminomethyl-cyclohexanecarboxylic acid, 95.0%, 10g

(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

3-(4-Chloro-3,5-dimethyl-pyrazol-1-yl)-butyric acid, 95.0%, 500mg

Pyrazolo[1,5-a]pyridin-5-ylmethanol, 95.0%, 250mg

2-Phenoxyacetonitrile, 95.0%, 100g

2,4-Difluoro-3-methylphenol, 97%, 250mg

2-(Pyrrolidin-3-yl)ethanol hydrochloride, 95.0%, 1g